In A First Of Sorts, GSK To Map Breast Cancer Sub-types In India For Research Leads
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - British drug maker GlaxoSmithKline is digging deeper into India - this time not to sell medicines but to study the causes of breast cancer